Literature DB >> 21670079

Inhibition of miR-193a expression by Max and RXRα activates K-Ras and PLAU to mediate distinct aspects of cellular transformation.

Dimitrios Iliopoulos1, Asaf Rotem, Kevin Struhl.   

Abstract

MicroRNA profiling in isogenic models of cellular transformation involving either breast epithelial cells or fibroblasts reveals that expression of miR-193a is lower in transformed cells than in nontransformed cells. The transcription factors Max and RXRα bind directly to the miR-193a promoter and inhibit miR-193a expression during transformation. miR-193a inhibits cellular transformation by directly targeting the 3' untranslated regions of PLAU and K-Ras. Interestingly, miR-193a controls anchorage-independent growth in soft agar through K-Ras, whereas it affects invasive growth through PLAU. miR-193a overexpression inhibits the tumorigenicity of developmentally diverse but not all cancer cell types, and it inhibits tumor growth in colon- and breast-derived xenografts. Finally, expression of miR-193a is inversely correlated with PLAU and K-Ras in human colon adenocarcinomas. Thus, a pathway in which Max and RXRα inhibit miR-193a expression, thereby activating the PLAU and K-Ras oncogenes is important for distinct aspects of cellular transformation, as well as tumor growth and colon (and perhaps other types of) cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670079      PMCID: PMC3148313          DOI: 10.1158/0008-5472.CAN-11-0425

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

Authors:  Ken-ichi Kozaki; Issei Imoto; Seiki Mogi; Ken Omura; Johji Inazawa
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 3.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

4.  Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.

Authors:  X-F Li; P-J Yan; Z-M Shao
Journal:  Oncogene       Date:  2009-08-24       Impact factor: 9.867

5.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

6.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

Authors:  Heather A Hirsch; Dimitrios Iliopoulos; Philip N Tsichlis; Kevin Struhl
Journal:  Cancer Res       Date:  2009-09-14       Impact factor: 12.701

7.  MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

Authors:  Sandrine Sander; Lars Bullinger; Kay Klapproth; Katja Fiedler; Hans A Kestler; Thomas F E Barth; Peter Möller; Stephan Stilgenbauer; Jonathan R Pollack; Thomas Wirth
Journal:  Blood       Date:  2008-08-19       Impact factor: 22.113

Review 8.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation.

Authors:  Bernd B Zeisig; Colin Kwok; Arthur Zelent; Pattabhiraman Shankaranarayanan; Hinrich Gronemeyer; Shuo Dong; Chi Wai Eric So
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

10.  MicroRNAs and cancer: short RNAs go a long way.

Authors:  Andrea Ventura; Tyler Jacks
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  49 in total

1.  miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

Authors:  Hongwei Liang; Minghui Liu; Xin Yan; Yong Zhou; Wengong Wang; Xueliang Wang; Zheng Fu; Nan Wang; Suyang Zhang; Yanbo Wang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Jing Li; Xi Chen
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Authors:  Peng Zhang; Deng-Bo Ji; Hai-Bo Han; Yun-Fei Shi; Chang-Zheng Du; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.

Authors:  Joel Pekow; Katherine Meckel; Urszula Dougherty; Yong Huang; Xindi Chen; Anas Almoghrabi; Reba Mustafi; Fatma Ayaloglu-Butun; Zifeng Deng; Haider I Haider; John Hart; David T Rubin; John H Kwon; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2017-06-09       Impact factor: 12.531

4.  Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples.

Authors:  Gerard J Nuovo; Michela Garofalo; Nicola Valeri; Vicki Roulstone; Stefano Volinia; David E Cohn; Mitch Phelps; Kevin J Harrington; Richard Vile; Alan Melcher; Evanthia Galanis; Sarah Sehl; Rob Adair; Karen Scott; Ailsa Rose; Giles Toogood; Matthew C Coffey
Journal:  Mod Pathol       Date:  2012-06-15       Impact factor: 7.842

5.  Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers.

Authors:  Zhe Ji; Lizhi He; Aviv Regev; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

Review 6.  Interplay between K-RAS and miRNAs.

Authors:  Bing Shui; Gaspare La Rocca; Andrea Ventura; Kevin M Haigis
Journal:  Trends Cancer       Date:  2022-01-31

7.  Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt.

Authors:  Manasvi S Shah; Eunjoo Kim; Laurie A Davidson; Jason M Knight; Roger S Zoh; Jennifer S Goldsby; Evelyn S Callaway; Beyian Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-19

8.  Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.

Authors:  Salil Sharma; Soban Umar; Francois Potus; Andrea Iorga; Gabriel Wong; David Meriwether; Sandra Breuils-Bonnet; Denise Mai; Kaveh Navab; David Ross; Mohamad Navab; Steeve Provencher; Alan M Fogelman; Sébastien Bonnet; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Circulation       Date:  2014-06-24       Impact factor: 29.690

9.  Proteomic consequences of a single gene mutation in a colorectal cancer model.

Authors:  Patrick J Halvey; Bing Zhang; Robert J Coffey; Daniel C Liebler; Robbert J C Slebos
Journal:  J Proteome Res       Date:  2011-12-13       Impact factor: 4.466

10.  Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.

Authors:  Haruo Nakano; Yoji Yamada; Tatsuya Miyazawa; Tetsuo Yoshida
Journal:  Int J Oncol       Date:  2013-04-15       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.